IL142989A0 - Nucleotide and protein sequences of nogo genes and methods based thereon - Google Patents
Nucleotide and protein sequences of nogo genes and methods based thereonInfo
- Publication number
- IL142989A0 IL142989A0 IL14298999A IL14298999A IL142989A0 IL 142989 A0 IL142989 A0 IL 142989A0 IL 14298999 A IL14298999 A IL 14298999A IL 14298999 A IL14298999 A IL 14298999A IL 142989 A0 IL142989 A0 IL 142989A0
- Authority
- IL
- Israel
- Prior art keywords
- nucleotide
- protein sequences
- methods based
- nogo
- nogo genes
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10744698P | 1998-11-06 | 1998-11-06 | |
PCT/US1999/026160 WO2000031235A2 (en) | 1998-11-06 | 1999-11-05 | Nucleotide and protein sequences of nogo genes and methods based thereon |
Publications (1)
Publication Number | Publication Date |
---|---|
IL142989A0 true IL142989A0 (en) | 2002-04-21 |
Family
ID=22316666
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL14298999A IL142989A0 (en) | 1998-11-06 | 1999-11-05 | Nucleotide and protein sequences of nogo genes and methods based thereon |
IL142989A IL142989A (en) | 1998-11-06 | 2001-05-06 | Nucleotide and protein sequences of nogo genes and methods based thereon |
IL198027A IL198027A (en) | 1998-11-06 | 2009-04-06 | Antibody of the NOGO gene, medicinal preparations containing the antibody and use of the antibody |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL142989A IL142989A (en) | 1998-11-06 | 2001-05-06 | Nucleotide and protein sequences of nogo genes and methods based thereon |
IL198027A IL198027A (en) | 1998-11-06 | 2009-04-06 | Antibody of the NOGO gene, medicinal preparations containing the antibody and use of the antibody |
Country Status (27)
Country | Link |
---|---|
US (4) | US7781188B1 (xx) |
EP (3) | EP2333064A1 (xx) |
JP (2) | JP2003531566A (xx) |
KR (1) | KR100728405B1 (xx) |
CN (3) | CN1721444A (xx) |
AT (1) | ATE435232T1 (xx) |
AU (1) | AU774367C (xx) |
BR (1) | BR9915137A (xx) |
CA (1) | CA2350395C (xx) |
CY (1) | CY1110679T1 (xx) |
CZ (1) | CZ304224B6 (xx) |
DE (1) | DE69941059D1 (xx) |
DK (1) | DK1124846T3 (xx) |
ES (2) | ES2529196T3 (xx) |
HK (1) | HK1038027A1 (xx) |
HU (1) | HUP0301829A3 (xx) |
IL (3) | IL142989A0 (xx) |
MX (1) | MXPA01004598A (xx) |
NO (1) | NO332460B1 (xx) |
NZ (1) | NZ511683A (xx) |
PL (1) | PL204293B1 (xx) |
PT (1) | PT1124846E (xx) |
RU (3) | RU2304585C2 (xx) |
SK (1) | SK287323B6 (xx) |
TR (1) | TR200700740T2 (xx) |
WO (1) | WO2000031235A2 (xx) |
ZA (1) | ZA200103714B (xx) |
Families Citing this family (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020072493A1 (en) * | 1998-05-19 | 2002-06-13 | Yeda Research And Development Co. Ltd. | Activated T cells, nervous system-specific antigens and their uses |
PT1098972E (pt) * | 1998-07-22 | 2010-12-14 | Smithkline Beecham Ltd | Proteína semelhante a proteína especificamente neuroendócrina e adnc codificante |
US7781188B1 (en) | 1998-11-06 | 2010-08-24 | University Of Zurich | Nucleotide and protein sequences of Nogo genes and methods based thereon |
US7186530B1 (en) | 2000-04-07 | 2007-03-06 | Chiron Corporation | Protein associated with cell stress response |
WO2000060083A1 (en) * | 1999-04-08 | 2000-10-12 | Chiron Corporation | Novel protein associated with cell stress response |
CZ20022438A3 (cs) * | 2000-01-12 | 2002-10-16 | Yale University | Nukleová kyselina kódující receptor Nogo, izolovaný polypeptid a farmaceutický přípravek pro stimulaci růstu axonů |
US7119165B2 (en) * | 2000-01-12 | 2006-10-10 | Yale University | Nogo receptor-mediated blockade of axonal growth |
US7049395B2 (en) | 2000-05-02 | 2006-05-23 | Yale University | Anti-inflammatory compounds and uses thereof |
ATE458815T1 (de) | 2000-10-06 | 2010-03-15 | Univ Yale | Homologe des nogo rezeptors |
GB0101312D0 (en) * | 2001-01-18 | 2001-02-28 | Glaxo Group Ltd | Assay |
GB0101313D0 (en) * | 2001-01-18 | 2001-02-28 | Glaxo Group Ltd | Assay |
AR040778A1 (es) | 2002-08-06 | 2005-04-20 | Glaxo Group Ltd | Anticuerpos alterados o fragmentos funcionales que se unen a mag (glicoproteina asociada a mielina). |
GB0228832D0 (en) | 2002-12-10 | 2003-01-15 | Novartis Ag | Organic compound |
US20060287501A1 (en) * | 2002-10-31 | 2006-12-21 | Pieris Proteolab Ag | Soluble truncated polypeptides of the nogo-a protein |
GB0306309D0 (en) | 2003-03-19 | 2003-04-23 | Glaxo Group Ltd | Method of treatment |
RS54160B1 (sr) | 2003-03-19 | 2015-12-31 | Biogen Idec Ma Inc. | Protein koji se vezuje za nogo receptor |
TWI329649B (en) * | 2003-12-22 | 2010-09-01 | Glaxo Group Ltd | Immunoglobulins |
CA2572193A1 (en) | 2004-06-24 | 2006-01-05 | Biogen Idec Ma Inc. | Treatment of conditions involving oligodendrocytes with sp35 based agents |
KR100659820B1 (ko) | 2004-11-17 | 2006-12-19 | 삼성에스디아이 주식회사 | 리튬 이온 이차 전지 |
SG157418A1 (en) * | 2004-12-01 | 2009-12-29 | Univ Singapore | Nogo a protein fragments as neuronal network- interacting peptides |
WO2007008732A2 (en) | 2005-07-07 | 2007-01-18 | Yale University | Compositions and methods for suppressing axonal growth inhibition |
EP2238986A3 (en) | 2005-07-08 | 2010-11-03 | Biogen Idec MA Inc. | Sp35 antibodies and uses thereof |
WO2007014382A1 (en) * | 2005-07-28 | 2007-02-01 | Wyeth | Compositions and methods of mutant nogo-66 domain proteins |
KR20080073748A (ko) | 2005-11-16 | 2008-08-11 | 노파르티스 아게 | 척수 손상에서의 항-nogo-a 항체 치료를 위한바이오마커 |
GB0525662D0 (en) | 2005-12-16 | 2006-01-25 | Glaxo Group Ltd | Immunoglobulins |
CA2653456A1 (en) * | 2006-05-24 | 2007-11-29 | Richard Daneman | Permeability of blood-brain barrier |
CN101015683B (zh) * | 2007-01-18 | 2010-07-21 | 复旦大学 | 人rtn4b蛋白在制备创伤愈合药物中的应用 |
BRPI0818928B1 (pt) * | 2007-11-02 | 2021-12-07 | Novartis Ag | Moléculas de ligação a nogo-a isoladas, seu método de produção e seu uso, polinucleotídeo isolado, vetor e sistema de expressão, célula hospedeira isolada, e composição farmacêutica |
US20090186423A1 (en) * | 2007-11-22 | 2009-07-23 | Symphogen A/S | Method for Characterization of a Recombinant Polyclonal Protein |
AU2009269099B2 (en) | 2008-07-09 | 2016-03-10 | Biogen Ma Inc. | Compositions comprising antibodies to LINGO or fragments thereof |
AU2010256880B2 (en) * | 2009-06-02 | 2015-01-22 | Opko Health, Inc. | Identification of small molecules recognized by antibodies in subjects with neurodegenerative diseases |
US8828390B2 (en) | 2010-07-09 | 2014-09-09 | Universitat Zurich | Uses of NOGO-A inhibitors and related methods |
RU2478646C1 (ru) * | 2011-11-28 | 2013-04-10 | Федеральное государственное бюджетное учреждение науки Институт молекулярной биологии им.В.А.Энгельгардта Российской академии наук (ИМБ РАН) | Способ получения высокоаффинных поликлональных антител |
JP2015518829A (ja) | 2012-05-14 | 2015-07-06 | バイオジェン・エムエイ・インコーポレイテッドBiogen MA Inc. | 運動ニューロンに関する状態の処置のためのlingo−2アンタゴニスト |
EA032285B1 (ru) * | 2013-08-08 | 2019-05-31 | Глобал Био Терапьютикс, Инк. | Прибор для инъекций с минимальным захватом и его использование |
KR101685109B1 (ko) * | 2014-12-22 | 2016-12-09 | 경북대학교 산학협력단 | 근육 분화, 재생, 또는 질환 상태와 관련된 노고-에이의 용도 |
CA2973266A1 (en) | 2015-01-08 | 2016-07-14 | Biogen Ma Inc. | Lingo-1 antagonists and uses for treatment of demyelinating disorders |
US20180015144A1 (en) * | 2015-01-27 | 2018-01-18 | Universitat Zurich | Agonists of the nogo-a s1pr pathway for the treatment of glioblastoma |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4196265A (en) * | 1977-06-15 | 1980-04-01 | The Wistar Institute | Method of producing antibodies |
CA1173823A (en) | 1980-08-26 | 1984-09-04 | Leonard M. Hjelmeland | Nondenaturing zwitterionic detergent for membrane biochemistry |
EP0155433A1 (en) | 1984-03-23 | 1985-09-25 | Adriano Fontana | Immunosuppressant factor |
CA1341401C (en) | 1984-03-23 | 2002-11-26 | Adriano Fontana | Immunosuppressant factor derived from human glioblastoma cells |
EP0233838A3 (en) | 1986-02-04 | 1990-01-31 | Incyte Pharmaceuticals, Inc. | Neurite-promoting factor and process for the manufacture thereof |
DE68927438T2 (de) | 1988-06-13 | 1997-03-20 | American Biogenetic Sciences | Verfahren zur herstellung monoklonaler antikörper mit hilfe eines keimfreien tieres |
US5250414A (en) | 1988-11-04 | 1993-10-05 | Erziehungsdirektion Of The Canton Zurich | Diagnostic methods using neurite growth regulatory factors |
CA1341050C (en) * | 1988-11-04 | 2000-07-11 | Martin E. Schwab | Neurite growth regulatory factors |
EP0396719B1 (en) | 1988-11-04 | 1995-07-05 | Erziehungsdirektion Of The Canton Zurich | Neurite growth regulatory factors |
WO1993000427A2 (en) * | 1991-06-24 | 1993-01-07 | Erziehungsdirektion Of The Canton Zurich | Neurite growth regulatory factors |
US5858708A (en) * | 1996-08-12 | 1999-01-12 | Bandman; Olga | Polynucleotides encoding two novel human neuroendocrine-specific proteins |
WO1998017687A2 (en) * | 1996-10-25 | 1998-04-30 | Genetics Institute, Inc. | Secreted proteins and polynucleotides encoding them |
EP1042470A2 (en) * | 1997-12-30 | 2000-10-11 | Chiron Corporation | Bone marrow secreted proteins and polynucleotides |
US6607879B1 (en) * | 1998-02-09 | 2003-08-19 | Incyte Corporation | Compositions for the detection of blood cell and immunological response gene expression |
US20020072493A1 (en) * | 1998-05-19 | 2002-06-13 | Yeda Research And Development Co. Ltd. | Activated T cells, nervous system-specific antigens and their uses |
PT1098972E (pt) | 1998-07-22 | 2010-12-14 | Smithkline Beecham Ltd | Proteína semelhante a proteína especificamente neuroendócrina e adnc codificante |
EP1107978A1 (en) * | 1998-08-24 | 2001-06-20 | Alphagene, Inc. | Secreted proteins and polynucleotides encoding them |
US7781188B1 (en) | 1998-11-06 | 2010-08-24 | University Of Zurich | Nucleotide and protein sequences of Nogo genes and methods based thereon |
WO2001036631A1 (en) * | 1999-11-15 | 2001-05-25 | Smithkline Beecham P.L.C. | Human nogo-c polynucleotide and polypeptide and their uses |
US20030134301A1 (en) * | 2001-07-27 | 2003-07-17 | Brooksbank Robert Alan | Identification and use of molecules implicated in pain |
-
1999
- 1999-11-05 US US09/830,972 patent/US7781188B1/en not_active Expired - Fee Related
- 1999-11-05 AT AT99972673T patent/ATE435232T1/de active
- 1999-11-05 NZ NZ511683A patent/NZ511683A/en not_active IP Right Cessation
- 1999-11-05 SK SK622-2001A patent/SK287323B6/sk not_active IP Right Cessation
- 1999-11-05 TR TR2007/00740T patent/TR200700740T2/xx unknown
- 1999-11-05 EP EP10175908A patent/EP2333064A1/en not_active Withdrawn
- 1999-11-05 ES ES09160978.4T patent/ES2529196T3/es not_active Expired - Lifetime
- 1999-11-05 RU RU2001115705/13A patent/RU2304585C2/ru not_active IP Right Cessation
- 1999-11-05 EP EP99972673A patent/EP1124846B1/en not_active Revoked
- 1999-11-05 KR KR1020017005721A patent/KR100728405B1/ko not_active IP Right Cessation
- 1999-11-05 CN CNA2005100700739A patent/CN1721444A/zh active Pending
- 1999-11-05 EP EP09160978.4A patent/EP2093294B1/en not_active Expired - Lifetime
- 1999-11-05 CN CN998153486A patent/CN1354755B/zh not_active Expired - Fee Related
- 1999-11-05 DE DE69941059T patent/DE69941059D1/de not_active Expired - Lifetime
- 1999-11-05 MX MXPA01004598A patent/MXPA01004598A/es not_active IP Right Cessation
- 1999-11-05 ES ES99972673T patent/ES2329635T3/es not_active Expired - Lifetime
- 1999-11-05 IL IL14298999A patent/IL142989A0/xx unknown
- 1999-11-05 WO PCT/US1999/026160 patent/WO2000031235A2/en active Application Filing
- 1999-11-05 PL PL362990A patent/PL204293B1/pl unknown
- 1999-11-05 AU AU14692/00A patent/AU774367C/en not_active Ceased
- 1999-11-05 CA CA2350395A patent/CA2350395C/en not_active Expired - Fee Related
- 1999-11-05 JP JP2000584046A patent/JP2003531566A/ja active Pending
- 1999-11-05 CZ CZ2001-1608A patent/CZ304224B6/cs not_active IP Right Cessation
- 1999-11-05 CN CN200910175738A patent/CN101684155A/zh active Pending
- 1999-11-05 PT PT99972673T patent/PT1124846E/pt unknown
- 1999-11-05 HU HU0301829A patent/HUP0301829A3/hu not_active Application Discontinuation
- 1999-11-05 BR BR9915137-5A patent/BR9915137A/pt not_active Application Discontinuation
- 1999-11-05 DK DK99972673T patent/DK1124846T3/da active
-
2001
- 2001-05-04 NO NO20012223A patent/NO332460B1/no not_active IP Right Cessation
- 2001-05-06 IL IL142989A patent/IL142989A/en not_active IP Right Cessation
- 2001-05-08 ZA ZA200103714A patent/ZA200103714B/en unknown
- 2001-12-13 HK HK01108747.8A patent/HK1038027A1/xx not_active IP Right Cessation
-
2004
- 2004-02-06 RU RU2004103555/13A patent/RU2358982C2/ru not_active IP Right Cessation
-
2005
- 2005-01-26 US US11/044,899 patent/US7425334B2/en not_active Expired - Fee Related
-
2008
- 2008-10-29 US US12/290,316 patent/US20090162367A1/en not_active Abandoned
-
2009
- 2009-02-03 RU RU2009103533/10A patent/RU2432364C2/ru not_active IP Right Cessation
- 2009-04-06 IL IL198027A patent/IL198027A/en not_active IP Right Cessation
- 2009-09-30 CY CY20091101017T patent/CY1110679T1/el unknown
-
2010
- 2010-10-13 US US12/903,300 patent/US20110086034A1/en not_active Abandoned
-
2012
- 2012-07-20 JP JP2012161500A patent/JP2012213406A/ja active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL142989A (en) | Nucleotide and protein sequences of nogo genes and methods based thereon | |
WO2000003685A3 (en) | Nitrilase homologs | |
HK1041009A1 (en) | Characterization of the soc/crac calcium channel protein family soc/crac | |
WO2001032910A3 (en) | 27 human secreted proteins | |
WO2001036432A3 (en) | 18 human secreted proteins | |
WO2001012776A3 (en) | 18 human secreted proteins | |
WO2001034768A3 (en) | 15 human secreted proteins | |
WO2001046394A3 (en) | Mammalian protein phosphatases | |
WO2000077026A8 (en) | 49 human secreted proteins | |
WO2000063230A3 (en) | 49 human secreted proteins | |
WO2001062891A3 (en) | 207 human secreted proteins | |
WO2000058339A3 (en) | 50 human secreted proteins | |
WO2001012775A8 (en) | 25 human secreted proteins | |
WO1999063094A3 (en) | Nucleotide and protein sequences of gpr1 and methods based thereon | |
WO2000061624A8 (en) | 48 human secreted proteins | |
WO2000043495A3 (en) | 33 human secreted proteins | |
WO2004074460A3 (en) | Nucleotide and protein sequences of coc genes and methods based thereon | |
ATE278011T1 (de) | Human dnase ii | |
WO2003052377A9 (en) | 41 human secreted proteins | |
WO2000061596A8 (en) | 50 human secreted proteins | |
WO2002099066A3 (en) | 20 human secreted proteins | |
WO2002057420A3 (en) | 50 human secreted proteins | |
WO2001034769A3 (en) | 24 human secreted proteins | |
WO2001034767A3 (en) | 22 human secreted proteins | |
WO2002026931A3 (en) | 71 human secreted proteins |